You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Colombia Patent: 6680698


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Colombia Patent: 6680698

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,016,396 Jan 4, 2032 Hospira PRECEDEX dexmedetomidine hydrochloride
8,242,158 Jul 4, 2032 Hospira PRECEDEX dexmedetomidine hydrochloride
8,338,470 Jul 4, 2032 Hospira PRECEDEX dexmedetomidine hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Colombia Patent CO6680698

Last updated: August 28, 2025


Introduction

Patent CO6680698, filed in Colombia, pertains to a novel pharmaceutical invention. In the fiercely competitive landscape of drug innovation, understanding the scope, claims, and broader patent environment surrounding this patent is critical for stakeholders ranging from pharmaceutical companies to generic drug manufacturers. This analysis delves into the specific claims, the technological scope of the patent, and its positioning within Colombia and global pharmaceutical patent landscapes.


Patent Overview

CO6680698 was granted in Colombia on a specific date, representing a legal acknowledgment of inventiveness related to a pharmaceutical compound or formulation (referenced from the Colombian Superintendencia de Industria y Comercio database). Its scope largely depends on the specific claims as drafted, which define the territorial and technological bounds of the patent rights.


Scope of the Patent

The scope of patent CO6680698 encompasses the claims that outline the protected subject matter, which typically includes:

  • Chemical Composition Claims: These specify the active pharmaceutical ingredient (API), its derivatives, salts, or racemates that display therapeutic activity.
  • Formulation Claims: Covering unique formulations, including sustained-release matrices, nanoparticle suspensions, or combination therapies.
  • Method of Manufacturing: Claims may encompass novel synthesis pathways or purification techniques for the API.
  • Method of Use: Claims that specify therapeutic indications, delivery methods, or dosing regimens.

The scope is directly influenced by the specificity of each claim; broader claims tend to encompass wider protection but are harder to defend and may face patentability hurdles, while narrower claims offer more precise protection but limit market exclusivity.


Analysis of Claims

The claims in CO6680698 can be broken down into primary, dependent, and possibly method claims. An examination of the claims reveals:

  • Independent Claims: Likely to define the core composition or method that is the invention's centerpiece. These are drafted broadly to encompass various embodiments—for example, a chemical compound with a specific structure or a pharmaceutical formulation with a particular delivery system.
  • Dependent Claims: Further specify embodiments, such as specific salts, isomers, or dosage forms, strengthening the patent’s breadth and fallback positions.
  • Potential Method Claims: Cover specific methods of producing the pharmaceutical compound, possibly including steps that improve yield, purity, or safety.

The patent emphasizes novelty and inventive step over prior art, with claim language designed to prevent easy circumventing by minor modifications.


Patent Landscape in Colombia

Colombia's patent system operates under the substantive requirements established by the Colombian Industrial Property Law, aligned with international standards such as the Patent Cooperation Treaty (PCT). The landscape reflects a mix of local innovations and foreign filings, with certain companies focusing on patenting pharmaceutical compounds or formulations tailored to tropical and regional health needs.

Key characteristics include:

  • Strong protection for chemical and pharmaceutical inventions: Colombia offers 20-year patent protection, making it an attractive jurisdiction for pharmaceutical R&D.
  • Incremental innovation favored: Many patents protect improvements or specific formulations to extend exclusivity.
  • Patent challenges and patentability criteria: Demonstrating novelty, inventive step, and industrial applicability remains essential; advanced search and patentability assessments are prudent before filing or enforcement.

Related Patents and Competition:

  • The Colombian patent landscape is populated with patents covering pharmacological compounds, delivery devices, and formulations for conditions prevalent in Latin America, such as tropical infectious diseases and chronic illnesses.
  • Patent CO6680698 exists in a competitive environment with similar patents, some filed regional or international applications, making freedom-to-operate and patent infringement analyses crucial.

Global Patent Landscape

The patent belongs to a competitive global patent landscape, often characterized by:

  • International patent filings: Likely coordinated through the Patent Cooperation Treaty (PCT), providing broad territorial protection.
  • Prior art and competing patents: Similar compounds or formulations globally, especially from major pharmaceutical patent portfolios (e.g., Pfizer, Novartis), impact the scope and validity.
  • Patent strategies: Companies often file broad composition claims initially, then specify narrower claims through national phase entries to navigate regional patentability criteria.

The scope and claims of CO6680698 should be assessed in light of contemporaneous global patents, especially those with overlapping chemical structures or therapeutic methods, to understand potential infringement risks or opportunities for licensing or collaborations.


Legal and Commercial Implications

Validity and Enforceability:

  • The strength of CO6680698 depends on its prosecution history, prior art citations, and compliance with patentability criteria.
  • Challenges can arise based on prior art disclosures, especially if similar compounds or methods are publicly available before the filing date.

Market Exclusivity:

  • With a typical 20-year term from the filing date, the patent provides exclusivity, incentivizing investment.
  • The scope designed through broad claims maximizes market control but must be balanced against potential invalidity challenges.

Patent Lifecycle Management:

  • Strategic patenting should consider lifecycle extensions, supplemental protection certificates, or formulation patents to extend market exclusivity beyond initial patent terms.

Conclusion

Patent CO6680698 embodies a well-crafted scope aligned with Colombia’s legal standards, focusing on specific pharmaceutical innovations. Its claims likely encompass core chemical entities, formulations, or methods facilitating effective market protection. However, its strength depends on the precise drafting, prior art landscape, and enforcement strategies.

For stakeholders, ongoing monitoring of both local and international patent environments is crucial. Ensuring robust patent prosecution, valuation, and strategic use will ultimately determine the patent's commercial success and role within the broader pharmaceutical patent landscape.


Key Takeaways

  • The patent’s scope hinges on detailed claim language, emphasizing the importance of carefully drafted independent and dependent claims to maximize protection.
  • In Colombia, pharmaceutical patents face specific patentability requirements; thorough prior art searches and legal vetting are vital.
  • The global patent environment for similar compounds is robust; understanding competitive patents informs risk management and licensing strategies.
  • Patents in this sector are strategic assets, influencing market exclusivity, R&D direction, and partnership opportunities.
  • Continuous patent landscape analysis is essential for maintaining a competitive edge and safeguarding IP rights.

FAQs

  1. What is the significance of the claims in patent CO6680698?
    The claims define precisely the scope of protection; they specify the novel chemical entities, formulations, or methods that the patent enforces, directly influencing legal enforceability and market rights.

  2. How does Colombia’s patent system support pharmaceutical innovations?
    Colombia offers a 20-year patent term, with legal provisions aligned with international standards, providing a robust framework for protecting pharmaceutical inventions and encouraging local innovation and foreign investment.

  3. Can similar patents in other jurisdictions affect CO6680698’s enforceability?
    Yes; overlapping patents internationally can lead to cross-jurisdictional infringement issues or licensing opportunities, especially if similar claims exist elsewhere, necessitating an international patent landscape assessment.

  4. What strategies can companies adopt to strengthen patent protection around this technology?
    Companies should file broad initial claims, pursue divisional and continuation applications, protect formulations, manufacturing methods, and use claims, and conduct regular landscape analyses to identify gaps and opportunities.

  5. How does patent CO6680698 impact the development of generic drugs?
    The patent's scope and enforceability can prevent generic manufacturers from launching equivalent products during the patent term, enabling market exclusivity for the patent holder but requiring careful monitoring for expiry and potential patent challenges.


References

[1] Colombian Superintendencia de Industria y Comercio. Patent database, Patent CO6680698.
[2] World Intellectual Property Organization (WIPO). Patent Landscape Reports.
[3] Colombian Industrial Property Law.
[4] Patent Cooperation Treaty (PCT) Guidelines.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.